New Breast Biopsy System Capable of RT Tissue Imaging
By Medimaging International staff writers
Posted on 14 Sep 2017
Image: The Brevera breast biopsy system (Photo courtesy of Hologic).
The commercial availability of a new, enhanced, groundbreaking real-time breast biopsy and verification system has been announced.
The system features a new transformational workflow intended to streamline the entire breast biopsy process, improve the patient experience, and save time and costs.
The Brevera breast biopsy system was developed by Hologic (Bedford, MA, USA) and uses the CorLumina imaging technology real-time breast biopsy and verification system. The Brevera can increase the accuracy of a biopsy at the point-of-care, and help clinicians by providing real-time imaging.
The system is the first integrated system that can provide real-time imaging, tissue acquisition, sample verification, and advanced post-biopsy handling. The system is designed for 3D and 2D breast biopsies. The Brevera system also features integration with a Picture Archiving and Communication System (PACS) to facilitate the transfer of patient records and advanced image sharing. The Brevera system is designed for use with the Affirm prone biopsy and breast biopsy guidance system, and the MultiCare Platinum system, also manufactured by Hologic.
Division president, Breast and Skeletal Health Solutions at Hologic, Pete Valenti, said, "We're proud to launch the Brevera system, a major breakthrough for radiologists who, for the first time, will be able to image and verify tissue samples in real-time in the procedure room. The Brevera system provides clinicians with more information at the point of care and women with a vastly improved experience, resulting in significant cost and timesavings without compromising accuracy or patient health outcomes. The system transforms the stereotactic breast biopsy procedure as we know it, and serves as further proof of Hologic's commitment to better serve the needs of our customers and their patients."